<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7582250</article-id><article-id pub-id-type="doi">10.3390/molecules25194435</article-id><article-id pub-id-type="publisher-id">molecules-25-04435</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Potential Treatment of Breast and Lung Cancer Using <italic>Dicoma anomala</italic>, an African Medicinal Plant</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8129-700X</contrib-id><name><surname>Chota</surname><given-names>Alexander</given-names></name></contrib><contrib contrib-type="author"><name><surname>George</surname><given-names>Blassan P.</given-names></name></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5002-827X</contrib-id><name><surname>Abrahamse</surname><given-names>Heidi</given-names></name><xref rid="c1-molecules-25-04435" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Rimpelov&#x000e1;</surname><given-names>Silvie</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-25-04435">Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa; <email>chotatimzy@gmail.com</email> (A.C.); <email>blassang@uj.ac.za</email> (B.P.G.)</aff><author-notes><corresp id="c1-molecules-25-04435"><label>*</label>Correspondence: <email>habrahamse@uj.ac.za</email>; Tel.: +27-11-559-6550; Fax: +27-11-559-6448</corresp></author-notes><pub-date pub-type="epub"><day>27</day><month>9</month><year>2020</year></pub-date><pub-date pub-type="collection"><month>10</month><year>2020</year></pub-date><volume>25</volume><issue>19</issue><elocation-id>4435</elocation-id><history><date date-type="received"><day>21</day><month>8</month><year>2020</year></date><date date-type="accepted"><day>25</day><month>9</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 by the authors.</copyright-statement><copyright-year>2020</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Globally, cancer has been identified as one of the leading causes of death in public health. Its etiology is based on consistent exposure to carcinogenic. Plant-derived anticancer compounds are known to be less toxic to the normal cells and are classified into acetylenic compounds, phenolics, terpenes, and phytosterols. <italic>Dicoma anomala</italic> is a perennial herb belonging to the family Asteraceae and is widely distributed in Sub-Saharan Africa and used in the treatment of cancer, malaria, fever, diabetes, ulcers, cold, and cough. This review aimed at highlighting the benefits of <italic>D. anomala</italic> in various therapeutic applications with special reference to the treatment of cancers and the mechanisms through which the plant-derived agents induce cell death.</p></abstract><kwd-group><kwd><italic>Dicoma</italic></kwd><kwd>cancer</kwd><kwd>bioactive compounds</kwd><kwd>medicinal plants</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-molecules-25-04435"><title>1. Introduction</title><p>Cancer has been identified as a major public health problem globally. In the United states, cancer is one of the leading causes of mortality [<xref rid="B1-molecules-25-04435" ref-type="bibr">1</xref>]. In Sub-Saharan Africa, prostate, breast, and cervical cancers are the most common with high incidence rates. The occurrence of these cancers in Sub-Saharan Africa is estimated to double up in next 20 years [<xref rid="B2-molecules-25-04435" ref-type="bibr">2</xref>]. The cancer incidence rate is estimated to increase 50% by 2030; the burden is mostly expected to increase in low- and middle-income countries [<xref rid="B3-molecules-25-04435" ref-type="bibr">3</xref>]. The incidence and mortality rate of cancer in low- and middle-income countries are significantly increasing, and Zambia is of no exception [<xref rid="B4-molecules-25-04435" ref-type="bibr">4</xref>]. In South Africa, the incidence rate and treatment options of lung cancer differ between provinces because the country is diverse in terms of culture and racial groups [<xref rid="B5-molecules-25-04435" ref-type="bibr">5</xref>]. Although the incidence rate of cancer in Africa is low when compared to other continents in the world, the mortality rates are, however, higher, which significantly reflects poor therapeutic outcomes [<xref rid="B6-molecules-25-04435" ref-type="bibr">6</xref>].</p><p>The risk factors associated with cancers are divided into two categories based on their biological nature and modifiability. These are intrinsic and non-intrinsic risk factors. Intrinsic risk factors are simply random errors, which occur during DNA replication. Non-intrinsic risk factors are furthermore divided into endogenous and exogenous risk factors. Endogenous factors include gender, biological aging, genetic susceptibility, hormones, growth factors, and inflammation. While exogenous factors include radiation, chemical carcinogens, tumor-causing viruses, bad lifestyles such as smoking, alcohol consumption, nutrition imbalance, and lack of exercise [<xref rid="B7-molecules-25-04435" ref-type="bibr">7</xref>]. There are different approaches that are being used in the treatment and management of cancer such as chemotherapy, radiotherapy, surgery, gene therapy, and immunotherapy [<xref rid="B8-molecules-25-04435" ref-type="bibr">8</xref>,<xref rid="B9-molecules-25-04435" ref-type="bibr">9</xref>]. Although these modern therapies have shown some effectiveness in the treatment of cancer, they also have adverse side effects [<xref rid="B8-molecules-25-04435" ref-type="bibr">8</xref>]. Therefore, the research is focusing on plants and plant-derived agents to develop potent drugs to treat cancers. Many plant species have shown medicinal properties that are used in the treatment and prevention of various diseases [<xref rid="B10-molecules-25-04435" ref-type="bibr">10</xref>]. However, it has been estimated that 50&#x02013;60% of people living with cancer in the United States utilize plant-derived agents as an alternative therapy. These plants derived agents may be administered alone or simultaneously with other therapies such as chemo or radiotherapy [<xref rid="B11-molecules-25-04435" ref-type="bibr">11</xref>].</p></sec><sec id="sec2-molecules-25-04435"><title>2. <italic>Dicoma</italic> Genus</title><p>The word <italic>Dicoma</italic> is derived from two Greek words &#x0201c;<italic>di</italic>&#x0201d; (two) and &#x0201c;<italic>Kome</italic>&#x0201d; (tuft hair) and the word &#x0201c;<italic>anomala</italic>&#x0201d; is of Latin origin means irregular. <italic>D. anomala</italic> is widely distributed in African countries such as South Africa, Angola, Burundi, Botswana, Democratic Republic of Congo (DRC), Rwanda, Tanzania, Zambia, and Zimbabwe [<xref rid="B12-molecules-25-04435" ref-type="bibr">12</xref>]. <italic>D. anomala</italic> is mostly grow in grassy and savanna areas [<xref rid="B13-molecules-25-04435" ref-type="bibr">13</xref>]. The genus <italic>Dicoma</italic> has more than 10 species (<xref rid="molecules-25-04435-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3-molecules-25-04435"><title>3. <italic>Dicoma anomala</italic></title><p><italic>Dicoma anomala</italic> (<italic>D. anomala</italic>) is commonly known as fever or stomach bush; it is a perennial herb belongs to the family Asteraceae. It has an erect stem covered with thin hairs and bears a tuber underground [<xref rid="B14-molecules-25-04435" ref-type="bibr">14</xref>]. As shown in <xref ref-type="fig" rid="molecules-25-04435-f001">Figure 1</xref>, <italic>D. anomala</italic> leaves are narrow, stalkless, and positioned onto the stem.</p><p>The leaves of <italic>D. anomala</italic> are rough and green, but most of the time, it appears grey. The flower appears like a cup with terminal heads that look white-pinkish in color [<xref rid="B12-molecules-25-04435" ref-type="bibr">12</xref>]. It is a native plant in Sub-Saharan Africa. In South Africa, <italic>D. anomala</italic> is widely distributed across the country and is predominantly found in Limpompo, Gauteng, North-West, Mpumalanga, KwaZulu-Natal, Free State, and Northern Cape provinces [<xref rid="B15-molecules-25-04435" ref-type="bibr">15</xref>]. In Africa, <italic>D. anomala</italic> plant has been used in the treatment of various diseases such as fever, diabetes, ulcers, cold, and cough [<xref rid="B14-molecules-25-04435" ref-type="bibr">14</xref>]. The ethnomedicinal use of <italic>D. anomala</italic> are wide; its roots are extensively used in the therapy of at least 66 diseases that affect humans and animals. However, South Africa has the highest number of ethnomedicinal uses of <italic>D. anomala</italic> with at least 37 records for the treatment of various human illnesses [<xref rid="B12-molecules-25-04435" ref-type="bibr">12</xref>]. Various medicinal uses of <italic>D. anomala</italic> species are shown in <xref rid="molecules-25-04435-t002" ref-type="table">Table 2</xref>.</p></sec><sec id="sec4-molecules-25-04435"><title>4. Role of Plants in Cancer Therapies</title><p>Plants play a very important role in the treatment of cancer. This is because many plant species possess novel chemicals that act as anticancer agents. The plant derived anticancer agents are shown to exhibit less side effects compared to many chemotherapeutic agents [<xref rid="B16-molecules-25-04435" ref-type="bibr">16</xref>]. In past years, herbs were used as a major treatment for various cancers in different including countries in Europe and the Middle East. According to various reports from the World Health Organization, many countries use herbal medicine as an approved cancer treatment. It is estimated that only 5&#x02013;15% of the herbs used in the treatment of cancer have been investigated for their anticancer properties [<xref rid="B17-molecules-25-04435" ref-type="bibr">17</xref>], and 50,000 to 80,000 plants worldwide are being used for various medicinal purposes [<xref rid="B18-molecules-25-04435" ref-type="bibr">18</xref>].</p><p>In order to prevent and reduce cancer incidence, researchers are trying to find alternative anticancer agents that will reduce the development of resistance caused during the chemotherapies [<xref rid="B19-molecules-25-04435" ref-type="bibr">19</xref>]. Two-thirds of cancer therapies are derived from plant-based agents, and they are classified based on their mechanism of action. A classic example of reactive oxygen species (ROS) inducer is thymoquinone, a bioactive compound extracted from plants [<xref rid="B17-molecules-25-04435" ref-type="bibr">17</xref>]. Apart from thymoquinone, <xref rid="molecules-25-04435-t003" ref-type="table">Table 3</xref> shows other plant-derived phytochemicals used in cancer therapies.</p></sec><sec id="sec5-molecules-25-04435"><title>5. Mechanisms of Plant-Derived Agents Induced Cell Death </title><p>The mechanism of action of plant-derived bioactive compounds involves inhibition of various cellular activities, and the potency of plant-derived chemical agents is dependent on the dosage [<xref rid="B30-molecules-25-04435" ref-type="bibr">30</xref>]. <xref ref-type="fig" rid="molecules-25-04435-f002">Figure 2</xref> illustrates various steps involved in tumor development and its fate. The first step involves the interaction of carcinogenic agents and reactive oxygen species (ROS) in the cell. Once inside, the carcinogens will interact with the genetic material of the cell leading to mutations. On the other hand, ROS interfere with the proteins and enzymatic activities of the cell. In step 6, the normal cell transforms into a cancerous cell, and step 7 shows the proliferation of cancer cells. The continuous proliferation of cancer cells leads to the formation of a tumor (step 8).</p><p>There are many studies conducted in the past decades. These studies reported that the in vitro activities of medicinal plants have originated from Egypt and Asian countries [<xref rid="B18-molecules-25-04435" ref-type="bibr">18</xref>]. However, the mechanism of action of plant-derived bioactive compounds is dependent upon the quality and quantity of the phytochemicals present in them. As illustrated in <xref ref-type="fig" rid="molecules-25-04435-f002">Figure 2</xref> (steps 9 and 10), the bioactive compounds are extracted from different parts of the plant and administered on the cancer cells. Once the cancer cells are treated with bioactive compounds, the cancer cells will then have two fates, as shown in steps 11 and 12, respectively. Under step 11, the cancer cells become normal after the treatment with bioactive compounds or the cells may enter in the apoptotic cell death phase by the action of phytochemicals (step 12) [<xref rid="B16-molecules-25-04435" ref-type="bibr">16</xref>].</p><p>The possible mechanism of action of plant-derived phytochemicals are shown in <xref ref-type="fig" rid="molecules-25-04435-f003">Figure 3</xref>, which involves either the activation or inhibition of cellular pathways. Bioactive compounds extracted from natural sources promote apoptotic pathways, immune responses, and autophagy and inhibits different phases of cell cycle as well as the migration and invasion of cancerous cells. It is scientifically evident that scutellarein phytocompounds possess anticancer properties against a broad spectrum of cancers, including breast, colon, lung, prostate, renal, and tongue cancers. These phytocompounds induce tumor cell death through multiple cellular pathways. The molecular targets include apoptosis, cell cycle arrest, and proliferative inhibition pathways [<xref rid="B31-molecules-25-04435" ref-type="bibr">31</xref>]. Scutellarein play an important role in tumor suppression in prostate cancer cells. They induce tumor cell death through upregulation of caspase 3, 9, G2/M-phase cell cycle arrests and Bax/Bcl-2 ratio, as shown in <xref ref-type="fig" rid="molecules-25-04435-f004">Figure 4</xref> [<xref rid="B16-molecules-25-04435" ref-type="bibr">16</xref>]. Scutellarein are also able to induce apoptotic activities in liver cancer cell line HepG2 through activation of caspase-3 enzymes and STAT3 signaling pathway [<xref rid="B32-molecules-25-04435" ref-type="bibr">32</xref>]. This phytochemical is also able to suppress the invasion and migration of human hepatocellular carcinomas via inhibition of Akt-STAT3/Girdin activities [<xref rid="B33-molecules-25-04435" ref-type="bibr">33</xref>]. This anticancer agent suppresses tumor growth and induces apoptotic activities against human colorectal cancer by regulating p53 [<xref rid="B34-molecules-25-04435" ref-type="bibr">34</xref>]. In breast cancer, scutellarein inhibits tumor proliferation and inversion via upregulation of Hippo/Yap signaling pathways [<xref rid="B35-molecules-25-04435" ref-type="bibr">35</xref>].</p><p>Cirsimaritin is a flavonoid with diversified pharmacological activities including antioxidant, anti-inflammatory, antimicrobial, anticancer, and enzyme inhibitory activities. This bioactive compound belongs to a class known as 7-O-methylated flavonoid [<xref rid="B36-molecules-25-04435" ref-type="bibr">36</xref>]. Its anticancer activities have been explored using different cancer cell lines, such as breast, lung, and gallbladder [<xref rid="B37-molecules-25-04435" ref-type="bibr">37</xref>]. This anticancer compound plays a vital role in angiogenesis inhibition through the downregulation of p-Akt, p-ERK, and VEGF in MDA-MB-231 breast cancer cells [<xref rid="B38-molecules-25-04435" ref-type="bibr">38</xref>]. In human gallbladder carcinoma GBC-SD cells, cirsimaritin inhibits the growth of cancerous cells through mitochondrial apoptosis. Cirsimaritin triggers endoplasmic reticulum stress by forming ROS, and it downregulates the phosphorylation of Akt [<xref rid="B39-molecules-25-04435" ref-type="bibr">39</xref>].</p><p>&#x003b2;-farnesene is one of the essential sesquiterpenes used in the treatment of different types of cancer including breast, lung, and prostate [<xref rid="B40-molecules-25-04435" ref-type="bibr">40</xref>,<xref rid="B41-molecules-25-04435" ref-type="bibr">41</xref>,<xref rid="B42-molecules-25-04435" ref-type="bibr">42</xref>]. This organic compound is suppressing tumor proliferation through tumor apoptotic pathways. In tumor apoptotic pathway, ROS are formed and induce mitochondrial damage leading to cytochrome c release. The released cytochrome c together with Apaf 1 creates apoptosome that activates caspase cascade to induce cell death [<xref rid="B43-molecules-25-04435" ref-type="bibr">43</xref>].</p><p>&#x003b2;-sitosterol is an important plant-derived bioactive compound used for the treatment of different medical conditions. It has diversified medicinal benefits such as anti-inflammatory, antioxidant, antidiabetic, antifertility, antimicrobial, immunomodulatory, and anticancer properties [<xref rid="B44-molecules-25-04435" ref-type="bibr">44</xref>]. &#x003b2;-sitosterol inhibits tumor cell proliferation and activates the apoptotic pathway of various cancer cell lines. Cancer cell lines through which &#x003b2;-sitosterol exerts its anticancer activities include, breast, colon, lung, gastric, and prostate cancers [<xref rid="B45-molecules-25-04435" ref-type="bibr">45</xref>]. In A549 cells, &#x003b2;-sitosterol target the enzyme Trx/Trx1 reductase to induce apoptosis through ROS and p53 activation [<xref rid="B46-molecules-25-04435" ref-type="bibr">46</xref>]. &#x003b2;-sitosterol anticancer activities have been explored and induce endoreduplication in HL60 and U937 cell lines via PI3K/Akt and Bcl-2 pathways. In pancreatic cancer cell lines, &#x003b2;-sitosterol inhibits tumor cell growth, inducing G0/G1-phase cell cycle arrest, and apoptotic activities, downregulates NF-kB activities, upregulates the expression of Bax, and downregulates the expression of Bcl-2 protein [<xref rid="B47-molecules-25-04435" ref-type="bibr">47</xref>].</p><p>A-Humulene is a naturally occurring bioactive compound isolated from <italic>Eupatorium odoratum</italic> L and has been explored for its anticancer properties. This compound uses various pathways to induce tumor cell death. In vitro effects of &#x003b1;-Humulene include increased production of ROS and inhibition of Akt activation [<xref rid="B42-molecules-25-04435" ref-type="bibr">42</xref>,<xref rid="B48-molecules-25-04435" ref-type="bibr">48</xref>].</p></sec><sec id="sec6-molecules-25-04435"><title>6. Major Anticancer Compounds of <italic>Dicoma</italic></title><p>There are various compounds that are extracted from <italic>Dicoma</italic> species. Out of all the <italic>Dicoma</italic> species, <italic>D. schinzii</italic>, <italic>D. capensis</italic>, <italic>D. anomala</italic>, and <italic>D. zeyheri</italic> have been investigated for medicinal use and were classified based on their phytochemical composition. However, only one species (<italic>D. schinzii</italic>) out of the four exhibited similarities in terms of bioactive compound composition. These compounds are classified into different groups: acetylenic compounds, phenolic acids, flavonoids, sesquiterpenes, triterpenes, and phytosterols. These natural compounds derived from plants are seen to be non-toxic to non-cancerous cells or normal cells, and these compounds are used in the treatment of different cancers such as breast, ovarian, prostate, and kidney [<xref rid="B12-molecules-25-04435" ref-type="bibr">12</xref>,<xref rid="B49-molecules-25-04435" ref-type="bibr">49</xref>].</p><p>The roots and leaves of <italic>Dicoma anomala</italic> are extensively used in the treatment of various diseases in Africa (<xref rid="molecules-25-04435-t002" ref-type="table">Table 2</xref>). <italic>D. anomala</italic> extracts exhibit anticancer properties that are widely used in the treatment of breast and lung cancers. The polyphenolic compounds from <italic>Dicoma</italic> species such as flavonoids, sesquiterpenes, phytosterols, and triterpenes, as shown in <xref rid="molecules-25-04435-t004" ref-type="table">Table 4</xref>, are considered to exhibit anticancer properties [<xref rid="B12-molecules-25-04435" ref-type="bibr">12</xref>].</p></sec><sec id="sec7-molecules-25-04435"><title>7. <italic>D. Anomala</italic> and Pharmacological Studies </title><p><italic>Dicoma anomala</italic> is a perennial herb that is widely distributed in Sub-Saharan Africa. Its aerial parts have been analyzed for the presence of phytochemical compounds [<xref rid="B15-molecules-25-04435" ref-type="bibr">15</xref>]. <italic>D. anomala</italic> has been studied for its pharmacological potential in the treatment of various diseases. <italic>D. anomala</italic> extracts are reported for their antibacterial, anti-inflammatory, antiviral, antioxidant, anticancer, and antiplasmodial properties [<xref rid="B58-molecules-25-04435" ref-type="bibr">58</xref>].</p><p>Vlietinck et al. (1995) evaluated the antibacterial properties of <italic>D. anomala</italic> root extract against various microorganisms including <italic>Microsporum canis</italic>, <italic>Candida albicans</italic>, <italic>Staphylococcus aureus</italic>, and <italic>Trichophyton mentagrophytes</italic> using agar well diffusion and dilution methods. Furthermore, they investigated the effects of <italic>D</italic>. <italic>anomala</italic> root extract on viruses such as coxsackie, herpes simplex, measles, semliki forest, and poliomyelitis through viral titer reduction [<xref rid="B12-molecules-25-04435" ref-type="bibr">12</xref>].</p><p>Becker et al. [<xref rid="B59-molecules-25-04435" ref-type="bibr">59</xref>] evaluated in vitro antiplasmodial activities of <italic>D. anomala</italic> subsp. <italic>Gerrardii</italic> extract. Phytochemicals such as eudesmanolide and dehydrobrachylaenolide were isolated and used in the in vitro parasite lactate dehydrogenase assay against plasmodium falciparum (p. falciparum). Dehydrobrachylaenolide demonstrated anti-malarial activities against plasmodium falciparum. Furthermore, <italic>D. anomala</italic> has anticancer properties that have motivated the researchers to focus on the field of biomedicine. Shafiq et al. [<xref rid="B53-molecules-25-04435" ref-type="bibr">53</xref>] evaluated the in vitro antiproliferative effects of silver nanoparticles synthesized from the roots of <italic>D. anomala</italic> Sond. against MCF-7 breast cancer cells and NF54 parasitic strains. The study revealed that silver nanoparticles conjugated sesquiterpene have antiparasitic activities against NF54 <italic>p. falciparum</italic> strain, and it exhibited anticancer properties by inducing oxidative damage in breast cancer cells. Asita and colleagues evaluated the modulation of <italic>D. anomala</italic> and Cyclophosphamide (CP) in mutagen induced genotoxicity [<xref rid="B60-molecules-25-04435" ref-type="bibr">60</xref>].</p><p>Steenkamp and Gouws in 2006 evaluated the cytotoxic properties of six plant extracts used in cancer therapy in South Africa. In the study, aqueous extract from <italic>Dicoma capensis</italic> demonstrated anticancer properties against three different breast cancer cell lines such as MCF-7, MDA-MB-231, and MCF-12A. The aqueous root extracts from <italic>Dicoma anomala</italic> were investigated for the possible postprandial extenuation in hyperglycaemia and how it modulates the activities of carbohydrate metabolising enzymes [<xref rid="B14-molecules-25-04435" ref-type="bibr">14</xref>]. Balogun and Ashafa evaluated the activities of <italic>D. anomala</italic> and <italic>Gazania krebsiana</italic> used by Basotho for the treatment of various diseases [<xref rid="B61-molecules-25-04435" ref-type="bibr">61</xref>].</p></sec><sec id="sec8-molecules-25-04435"><title>8. Cancer Stem Cell Treatment</title><p>Stem cells are unspecialized body cells that have the ability to replicate and make well-differentiated specialized cells. These cells are isolated from inner mass of a cell, which is 5&#x02013;8 days old. The use of stem cells in a clinical setup is restricted due to ethical, legal, and religious controversies [<xref rid="B62-molecules-25-04435" ref-type="bibr">62</xref>]. Stem cells can be obtained from two main sources: adult and embryonic cells such as blood and placenta [<xref rid="B62-molecules-25-04435" ref-type="bibr">62</xref>,<xref rid="B63-molecules-25-04435" ref-type="bibr">63</xref>]. Stem cell therapy has various applications in a clinical setup including, cardiac, brain, skin, liver, and cancers [<xref rid="B64-molecules-25-04435" ref-type="bibr">64</xref>]. The mechanism through which <italic>D. anomala</italic> regulates the cancer stem cell activities is not clear, but various studies show effective regulation of cancer stem cell signaling pathways. However, many plant-derived anticancer compounds target the surface targeting antibodies of cancer stem cell (CSC), such as those found on breast cancer stem cells (anti-CD133, CD44, and anti-EpCAM). These anticancer compounds may also target the ABC cassette, immune-evasion antibodies, and cytokines [<xref rid="B65-molecules-25-04435" ref-type="bibr">65</xref>].</p></sec><sec id="sec9-molecules-25-04435"><title>9. Breast Cancer</title><p>According to the global burden of disease (GBD) report of 2015, cancer is the second leading cause of death globally [<xref rid="B66-molecules-25-04435" ref-type="bibr">66</xref>]. The global statistics show that 18.1 million new cases of breast cancer and 9.6 million deaths were reported in 2018. Breast cancer accounts up to 38.5% of female cancers [<xref rid="B67-molecules-25-04435" ref-type="bibr">67</xref>]. It was also estimated that globally in next 5 years, the prevalence of breast cancer will be around 43.8 million [<xref rid="B68-molecules-25-04435" ref-type="bibr">68</xref>]. Despite the incidence rate being low, the mortality rate of breast cancer among black African people remains higher than 40% [<xref rid="B69-molecules-25-04435" ref-type="bibr">69</xref>].</p><p>Cancer is mainly classified based on origin. Breast cancer is named after the breast tissue with erratic growth and proliferation of cells. The breast is mainly composed of two different vital tissues: stromal and glandular tissues. The stromal tissue also known as supporting tissue, which includes fatty and fibrous connective tissues, while the glandular tissues are made up of lobules and ducts [<xref rid="B70-molecules-25-04435" ref-type="bibr">70</xref>].</p><p>There are many types of cancer that develop in various parts of the breast. Most of them develop from the cells lining the ducts and the lobules [<xref rid="B70-molecules-25-04435" ref-type="bibr">70</xref>]. These types of cancer are in situ or invasive. The two main types of breast carcinoma in situ are ductal carcinoma and lobular carcinoma. Ductal carcinoma in situ is known to be the precursor of invasive cancer, while lobular carcinoma in situ is a benign condition [<xref rid="B71-molecules-25-04435" ref-type="bibr">71</xref>].</p><p>There are various risk factors that are associated with development of breast cancer. These risk factors including aging, family history, low parity, estrogen, and life styles such as alcohol abuse can lead to the development of breast cancer. There have been advancements in clinical and breast cancer related theoretical studies. However, these studies have helped in the development of breast cancer preventive measures. Currently, breast cancer preventive measures include screening, biological prevention, and chemoprevention [<xref rid="B72-molecules-25-04435" ref-type="bibr">72</xref>].</p><p>The treatment and management of breast cancer is dependent on the stage and type of tumor. The common treatment modalities for breast cancer include chemotherapy, surgery, human epidermal growth factor receptor 2 (<italic>HER-2</italic>) directed therapy, endocrine therapy, and radiotherapy [<xref rid="B73-molecules-25-04435" ref-type="bibr">73</xref>]. The introduction of natural plant-derived anticancer compounds has improved in the treatment of various cancers including breast cancer. Several reviews have highlighted the benefits of naturally derived phytochemicals as compared to the synthetic compounds. Some of the common natural bioactive phytochemicals used in anticancer therapies are vitamin E, hydroxytyrosol, resveratrol, etc. Apigenin is a phytochemical extracted from parsley vegetables are known to demonstrate cytotoxic activities against colon and breast cancer cell-lines [<xref rid="B10-molecules-25-04435" ref-type="bibr">10</xref>].</p></sec><sec id="sec10-molecules-25-04435"><title>10. Lung Cancer</title><p>Lung cancer is the most common neoplasm that occurs among men and women in most countries. The GLOBOCAN 2012 estimated a total of 1,242,000 new cases in men and 583,000 in women. Lung cancer is histologically classified into two classes. These classes include small-cell and non-small-cell lung cancers (NSCLC). In the United States, it was approximated that 200,000 persons were diagnosed with lung cancer in 2010 and 160,000 deaths were reported. It is the main cause of mortality in both men and women. Approximately 27% of cancer deaths, which was reported in the USA during 2015 and 20% deaths reported from European Union in 2016 were due to lung cancer [<xref rid="B74-molecules-25-04435" ref-type="bibr">74</xref>]. Tobacco usage is the well-known risk factor that accounts for 80% to 90% of lung cancer development [<xref rid="B75-molecules-25-04435" ref-type="bibr">75</xref>]. There are various risk factors that are associated with the development of lung cancer. The major risk factors include age and cigarette smoking. Cigarette smoking increased dramatically in the United States of America and the European countries [<xref rid="B76-molecules-25-04435" ref-type="bibr">76</xref>].</p><p>Physical examinations, radiological imaging, and biopsy tests are performed in non-small-cell lung cancer, and the staging is based on the outcome of these investigations. Surgery can be performed in order to determine the pathological stage of cancer by direct examination of biopsies [<xref rid="B77-molecules-25-04435" ref-type="bibr">77</xref>]. Most medical centers and hospitals have adopted the TNM staging system used in the staging of cancer where T is the size of the tumor; N is the number of lymph nodes that are infected, while M refers to the level of metastasis [<xref rid="B78-molecules-25-04435" ref-type="bibr">78</xref>].</p><p>Therapeutic approaches to be employed in the treatment of lung cancer are dependent on the stage of cancer. Currently lung cancer is treated by chemotherapy, immunotherapy, targeted therapy, and radiotherapy. Although immunotherapy has made tremendous progress in the treatment and management of lung cancer, chemotherapy is the current standard treatment to be employed in the first and second line in the management of small-cell lung cancer (SCLC) [<xref rid="B79-molecules-25-04435" ref-type="bibr">79</xref>]. Pre-clinical trials of 6-Shogaol, a bioactive compound extracted from ginger, have shown effectiveness in the treatment of non-small-cell lung cancer (NSCLC). In an experimental model involving a nude mouse, 6-Shogaol inhibited the growth of lung cancer cells. The growth inhibition of NSCLC was significantly associated with the decreased proliferation and increased apoptosis induction [<xref rid="B27-molecules-25-04435" ref-type="bibr">27</xref>].</p></sec><sec id="sec11-molecules-25-04435"><title>11. Colorectal Cancer</title><p>Colorectal cancer is the second cause of cancer-related death in the United States. Globally, colorectal cancer is the third leading cause of death in both men and females. According to the GLOBOCAN report of 2018, colorectal cancer is the fourth common diagnosed type of cancer [<xref rid="B80-molecules-25-04435" ref-type="bibr">80</xref>]. The increasing incidence rate of colorectal cancer in developed countries can be related to risk factors such as dietary, smoking, obesity, and age [<xref rid="B81-molecules-25-04435" ref-type="bibr">81</xref>]. Surgery remains the primary treatment modality if early diagnosed [<xref rid="B82-molecules-25-04435" ref-type="bibr">82</xref>]. The introduction of plant-derived phytochemicals plays an important role in the treatment and management of colorectal cancer. Phytochemicals of natural origin inhibit colorectal tumor growth through pathways such as phosphoinositide 3-kinase (PI3 kinase), STAT 3, and Wnt signaling pathway [<xref rid="B10-molecules-25-04435" ref-type="bibr">10</xref>].</p></sec><sec id="sec12-molecules-25-04435"><title>12. Prostate Cancer</title><p>Prostate cancer is one of the most commonly diagnosed cancers found in men after lung cancer. Despite advancements in the treatment of cancer and research, prostate cancer deaths had risen to more than 300,000 deaths worldwide. The risk factors related to one developing prostate cancer include age and family history [<xref rid="B83-molecules-25-04435" ref-type="bibr">83</xref>]. When compared to other countries, prostate cancer is more diagnosed in American and European men [<xref rid="B84-molecules-25-04435" ref-type="bibr">84</xref>]. Therapeutic approaches to be employed in the treatment prostate cancer include chemotherapy, prostatectomy, and radiation therapy [<xref rid="B85-molecules-25-04435" ref-type="bibr">85</xref>].</p></sec><sec id="sec13-molecules-25-04435"><title>13. Scope and Importance of <italic>Dicoma</italic> in Anticancer Research</title><p>Plants are reservoirs of various phytochemicals [<xref rid="B68-molecules-25-04435" ref-type="bibr">68</xref>]. Tumor recurrence and side effects elicited by chemotherapy have reduced the efficacy of most of the anticancer agents. Phytochemical constituents from <italic>D. anomala</italic> play a very important role in the development of new potent anticancer agents. Apart from being widely used in therapeutic purposes, <italic>D. anomala</italic> extracts are also used in industries to manufacture drugs, herbicides, and cosmetics [<xref rid="B86-molecules-25-04435" ref-type="bibr">86</xref>]. Combination of alkaloid derivatives with other therapeutic agents proved to be more effective in the treatment of different types of cancer [<xref rid="B87-molecules-25-04435" ref-type="bibr">87</xref>].</p></sec><sec id="sec14-molecules-25-04435"><title>14. Combination Therapies Using Plant-Derived Phytochemicals</title><p>Cancer is a global health problem that leads to increased morbidity and mortality. Therefore, various research projects are focusing on the development of effective therapeutic approaches that will prolong human lives. Combination of cancer therapies is aimed to reduce the possibility of drug resistance during chemotherapy [<xref rid="B88-molecules-25-04435" ref-type="bibr">88</xref>]. Since 4500 BC, plant extracts have been used in traditional practices by Indian and Chinese people. Advances in analytical chemistry have improved in the investigation of plant-derived extracts for potential medicinal components [<xref rid="B27-molecules-25-04435" ref-type="bibr">27</xref>]. Combined therapy is the new direction taken to fight against cancer. It has a high efficacy when compared to monotherapy and provides an improved treatment efficacy and with minimal adverse effects [<xref rid="B89-molecules-25-04435" ref-type="bibr">89</xref>].</p></sec><sec sec-type="conclusions" id="sec15-molecules-25-04435"><title>15. Conclusions and Future Perspectives</title><p>Due to an increased resistance and adverse side effects exhibited by radiotherapy and chemotherapy, plant-derived bioactive compounds are considered as a potential source of anticancer agents with less side effects and cost effectiveness. Not only in cancer treatment, phytochemicals of plant origin are used by most countries in the treatment of various medical conditions. Bioactive phytochemicals are known to have anticancer, antibacterial, anti-inflammatory, antiviral, antioxidants, and antiplasmodial properties. Therefore, more efforts are being made by researchers to explore different plant extracts and identify the potent active principle compounds. Present research outcomes create a baseline for the validation and standardization of plant-derived drugs. <italic>D. anomala</italic>, one of the little-known African medicinal plants, has diversified pharmacological and phytochemical properties that need to be subjected to a detailed evaluation with special reference to cancer.</p><p>Due to the diversified pharmacological properties of plant-derived bioactive compounds, many researchers are focusing on developing plant-derived products for cancer treatments. Stem cell therapy by using plant-derived bioactive compounds and targeted biomarker development will replace the current synthetic ones. There are many anticancer phytochemicals without a clear mechanism of action, hence many of these compounds have to be subjected to clinical trials. Clinical trials are important, because they help in validating efficacies and adverse effects associated with those compounds. Combining traditional medicinal practices with modern treatments is one of the suggested approaches in the treatment and management of various types cancer for improved effectiveness.</p></sec></body><back><ack><title>Acknowledgments</title><p>The authors sincerely thank the Department of science and technology and national Research foundation of South Africa, Laser Research Centre (LRC) and the University of Johannesburg for the support.</p></ack><notes><title>Author Contributions</title><p>Conceptualization and writing, A.C.; review and editing, A.C.; B.P.G. and H.A.; supervision, B.P.G. and H.A. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This work is supported by the South African Research Chairs initiative of the Department of science and technology and National Research Foundation of South Africa (Grant No 98337), as well as grants received from the University of Johannesburg (URC) and the Council for Scientific and Industrial Research (CSIR)-National Laser Centre (NLC).</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>We wish to confirm that there are no known conflicts of interest associated with this publication.</p></notes><ref-list><title>References</title><ref id="B1-molecules-25-04435"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siegel</surname><given-names>R.L.</given-names></name><name><surname>Miller</surname><given-names>K.D.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name></person-group><article-title>Cancer statistics, 2020</article-title><source>CA Cancer. J. Clin.</source><year>2020</year><volume>70</volume><fpage>7</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.3322/caac.21590</pub-id><?supplied-pmid 31912902?><pub-id pub-id-type="pmid">31912902</pub-id></element-citation></ref><ref id="B2-molecules-25-04435"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rebbeck</surname><given-names>T.R.</given-names></name></person-group><article-title>Cancer in sub-Saharan Africa</article-title><source>Science</source><year>2020</year><volume>367</volume><fpage>27</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1126/science.aay4743</pub-id><?supplied-pmid 31896706?><pub-id pub-id-type="pmid">31896706</pub-id></element-citation></ref><ref id="B3-molecules-25-04435"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moodley</surname><given-names>J.</given-names></name><name><surname>Walter</surname><given-names>F.M.</given-names></name><name><surname>Scott</surname><given-names>S.E.</given-names></name><name><surname>Mwaka</surname><given-names>A.M.</given-names></name></person-group><article-title>Towards timely diagnosis of symptomatic breast and cervical cancer in South Africa</article-title><source>S. Afr. Med. J.</source><year>2018</year><volume>108</volume><fpage>803</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.7196/SAMJ.2018.v108i10.13478</pub-id><pub-id pub-id-type="pmid">30421705</pub-id></element-citation></ref><ref id="B4-molecules-25-04435"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cabanes</surname><given-names>A.</given-names></name><name><surname>Kapambwe</surname><given-names>S.</given-names></name><name><surname>Citonje-Msadabwe</surname><given-names>S.</given-names></name><name><surname>Parham</surname><given-names>G.P.</given-names></name><name><surname>Lishimpi</surname><given-names>K.</given-names></name><name><surname>Cruz</surname><given-names>T.A.</given-names></name><name><surname>Shastri</surname><given-names>S.</given-names></name></person-group><article-title>Challenges, Opportunities, and Priorities for Advancing Breast Cancer Control in Zambia: A Consultative Meeting on Breast Cancer Control</article-title><source>J. Glob. Oncol.</source><year>2019</year><pub-id pub-id-type="doi">10.1200/JGO.18.00222</pub-id><?supplied-pmid 30908146?><pub-id pub-id-type="pmid">30908146</pub-id></element-citation></ref><ref id="B5-molecules-25-04435"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eeden</surname><given-names>R.</given-names></name><name><surname>van Tunmer</surname><given-names>M.</given-names></name><name><surname>Geldenhuys</surname><given-names>A.</given-names></name><name><surname>Nayler</surname><given-names>S.</given-names></name><name><surname>Rapoport</surname><given-names>B.L.</given-names></name></person-group><article-title>Lung Cancer in South Africa</article-title><source>J. Thorac. Oncol.</source><year>2020</year><volume>15</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2019.06.032</pub-id><pub-id pub-id-type="pmid">31864550</pub-id></element-citation></ref><ref id="B6-molecules-25-04435"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joko-Fru</surname><given-names>W.Y.</given-names></name><name><surname>Miranda-Filho</surname><given-names>A.</given-names></name><name><surname>Soerjomataram</surname><given-names>I.</given-names></name><name><surname>Egue</surname><given-names>M.</given-names></name><name><surname>Akele-Akpo</surname><given-names>M.T.</given-names></name><name><surname>N&#x02019;da</surname><given-names>G.</given-names></name><name><surname>Assefa</surname><given-names>M.</given-names></name><name><surname>Buziba</surname><given-names>N.</given-names></name><name><surname>Korir</surname><given-names>A.</given-names></name><name><surname>Kamate</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: A population-based registry study</article-title><source>Int. J. Cancer</source><year>2020</year><volume>146</volume><fpage>1208</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1002/ijc.32406</pub-id><pub-id pub-id-type="pmid">31087650</pub-id></element-citation></ref><ref id="B7-molecules-25-04435"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>S.</given-names></name><name><surname>Zhu</surname><given-names>W.</given-names></name><name><surname>Thompson</surname><given-names>P.</given-names></name><name><surname>Hannun</surname><given-names>Y.A.</given-names></name></person-group><article-title>Evaluating intrinsic and non-intrinsic cancer risk factors</article-title><source>Nat. Commun.</source><year>2018</year><volume>9</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41467-018-05467-z</pub-id><pub-id pub-id-type="pmid">29317637</pub-id></element-citation></ref><ref id="B8-molecules-25-04435"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chota</surname><given-names>A.</given-names></name><name><surname>Kruger</surname><given-names>W.</given-names></name><name><surname>Pienaar</surname><given-names>J.</given-names></name></person-group><article-title>Immunotherapy for Treatment of Resistant Cancer</article-title><source>J. Med. Lab. Sci. Technol. S. Afr.</source><year>2019</year><volume>1</volume><fpage>18</fpage><lpage>24</lpage></element-citation></ref><ref id="B9-molecules-25-04435"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pucci</surname><given-names>C.</given-names></name><name><surname>Martinelli</surname><given-names>C.</given-names></name><name><surname>Ciofani</surname><given-names>G.</given-names></name></person-group><article-title>Innovative approaches for cancer treatment: Current perspectives and new challenges</article-title><source>Ecancermedicalscience</source><year>2019</year><fpage>13</fpage><pub-id pub-id-type="doi">10.3332/ecancer.2019.961</pub-id></element-citation></ref><ref id="B10-molecules-25-04435"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Khor</surname><given-names>T.O.</given-names></name><name><surname>Shu</surname><given-names>L.</given-names></name><name><surname>Su</surname><given-names>Z.</given-names></name><name><surname>Fuentes</surname><given-names>F.</given-names></name><name><surname>Lee</surname><given-names>J.H.</given-names></name><name><surname>Kong</surname><given-names>A.N.T.</given-names></name></person-group><article-title>Plants Against Cancer: A Review on Natural Phytochemicals in Preventing and Treating Cancers and Their Druggability</article-title><source>Anticancer Agents Med. Chem.</source><year>2012</year><volume>12</volume><fpage>1281</fpage><lpage>1305</lpage><pub-id pub-id-type="doi">10.2174/187152012803833026</pub-id><pub-id pub-id-type="pmid">22583408</pub-id></element-citation></ref><ref id="B11-molecules-25-04435"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gutheil</surname><given-names>W.G.</given-names></name><name><surname>Reed</surname><given-names>G.</given-names></name><name><surname>Ray</surname><given-names>A.</given-names></name><name><surname>Anant</surname><given-names>S.</given-names></name><name><surname>Dhar</surname><given-names>A.</given-names></name></person-group><article-title>Crocetin: An agent derived from saffron for prevention and therapy for cancer</article-title><source>Curr. Pharm. Biotechnol.</source><year>2012</year><volume>13</volume><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.2174/138920112798868566</pub-id><pub-id pub-id-type="pmid">21466430</pub-id></element-citation></ref><ref id="B12-molecules-25-04435"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maroyi</surname><given-names>A.</given-names></name></person-group><article-title><italic>Dicoma anomala</italic> Sond.: A Review of Its Botany, Ethnomedicine, Phytochemistry And Pharmacology</article-title><source>Asian J. Pharm. Clin. Res.</source><year>2018</year><volume>11</volume><fpage>70</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.22159/ajpcr.2018.v11i6.25538</pub-id></element-citation></ref><ref id="B13-molecules-25-04435"><label>13.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Herbert</surname><given-names>O.</given-names></name></person-group><source>Butterflies of the Kruger National Park and Surrounds</source><publisher-name>Penguin Random House South Africa</publisher-name><publisher-loc>Cape Town, South Africa</publisher-loc><year>2015</year></element-citation></ref><ref id="B14-molecules-25-04435"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balogun</surname><given-names>F.O.</given-names></name><name><surname>Ashafa</surname><given-names>A.O.T.</given-names></name></person-group><article-title>Aqueous root extracts of <italic>Dicoma anomala</italic> (Sond.) extenuates postprandial hyperglycaemia in vitro and its modulation on the activities of carbohydrate-metabolizing enzymes in streptozotocin-induced diabetic Wistar rats</article-title><source>S. Afr. J. Bot.</source><year>2017</year><volume>112</volume><fpage>102</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2017.05.014</pub-id></element-citation></ref><ref id="B15-molecules-25-04435"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsabisa</surname><given-names>M.G.</given-names></name><name><surname>Chukwuma</surname><given-names>C.I.</given-names></name><name><surname>Chaudhary</surname><given-names>S.K.</given-names></name><name><surname>Kumar</surname><given-names>C.S.</given-names></name><name><surname>Baleni</surname><given-names>R.</given-names></name><name><surname>Javu</surname><given-names>M.</given-names></name><name><surname>Oyedemi</surname><given-names>S.O.</given-names></name></person-group><article-title><italic>Dicoma anomala</italic> (Sond.) abates glycation and DPP-IV activity and modulates glucose utilization in Chang liver cells and 3T3-L1 adipocytes</article-title><source>S. Afr. J. Bot.</source><year>2020</year><volume>128</volume><fpage>182</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.sajb.2019.09.013</pub-id></element-citation></ref><ref id="B16-molecules-25-04435"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Abbasi</surname><given-names>B.A.</given-names></name><name><surname>Mahmood</surname><given-names>T.</given-names></name><name><surname>Kanwal</surname><given-names>S.</given-names></name><name><surname>Ali</surname><given-names>B.</given-names></name><name><surname>Shah</surname><given-names>S.A.</given-names></name><name><surname>Khalil</surname><given-names>A.T.</given-names></name></person-group><article-title>Plant-derived anticancer agents: A green anticancer approach</article-title><source>Asian Pac. J. Trop. Biomed.</source><year>2017</year><volume>7</volume><fpage>1129</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1016/j.apjtb.2017.10.016</pub-id></element-citation></ref><ref id="B17-molecules-25-04435"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hassan</surname><given-names>B.</given-names></name></person-group><article-title>Plants and Cancer Treatment</article-title><source>Med. Plants Use Prev. Treat. Dis.</source><year>2019</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.5772/intechopen.90568</pub-id></element-citation></ref><ref id="B18-molecules-25-04435"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Darwish</surname><given-names>M.S.</given-names></name><name><surname>Efferth</surname><given-names>T.</given-names></name></person-group><article-title>Medicinal Plants from Near East for Cancer Therapy</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3389/fphar.2018.00056</pub-id><pub-id pub-id-type="pmid">29387012</pub-id></element-citation></ref><ref id="B19-molecules-25-04435"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>R.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name><name><surname>Naqvi</surname><given-names>A.A.</given-names></name><name><surname>Shehzad</surname><given-names>A.</given-names></name><name><surname>Al-Ghamdi</surname><given-names>M.S.</given-names></name></person-group><article-title>Role of traditional Islamic and Arabic plants in cancer therapy</article-title><source>J. Tradit. Complement. Med.</source><year>2017</year><volume>7</volume><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.jtcme.2016.05.002</pub-id><pub-id pub-id-type="pmid">28417090</pub-id></element-citation></ref><ref id="B20-molecules-25-04435"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>W.-Q.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><name><surname>Guo</surname><given-names>X.-F.</given-names></name><name><surname>Liu</surname><given-names>Z.</given-names></name><name><surname>Dong</surname><given-names>W.-G.</given-names></name></person-group><article-title>Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro</article-title><source>World J. Gastroenterol.</source><year>2016</year><volume>22</volume><fpage>4149</fpage><lpage>4159</lpage><pub-id pub-id-type="doi">10.3748/wjg.v22.i16.4149</pub-id><pub-id pub-id-type="pmid">27122665</pub-id></element-citation></ref><ref id="B21-molecules-25-04435"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>J.H.</given-names></name><name><surname>Cheng</surname><given-names>C.W.</given-names></name><name><surname>Yang</surname><given-names>Y.C.</given-names></name><name><surname>Chen</surname><given-names>W.S.</given-names></name><name><surname>Hung</surname><given-names>W.Y.</given-names></name><name><surname>Chow</surname><given-names>J.M.</given-names></name><name><surname>Chen</surname><given-names>P.S.</given-names></name><name><surname>Hsiao</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>W.J.</given-names></name><name><surname>Chien</surname><given-names>M.H.</given-names></name></person-group><article-title>Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses</article-title><source>J. Exp. Clin. Cancer Res.</source><year>2018</year><volume>37</volume><fpage>199</fpage><pub-id pub-id-type="doi">10.1186/s13046-018-0869-1</pub-id><pub-id pub-id-type="pmid">30134935</pub-id></element-citation></ref><ref id="B22-molecules-25-04435"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M.O.</given-names></name><name><surname>Lee</surname><given-names>M.H.</given-names></name><name><surname>Oi</surname><given-names>N.</given-names></name><name><surname>Kim</surname><given-names>S.H.</given-names></name><name><surname>Bae</surname><given-names>K.B.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Kim</surname><given-names>D.J.</given-names></name><name><surname>Reddy</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>S.Y.</given-names></name><name><surname>Park</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>[6]-Shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2</article-title><source>Carcinogenesis</source><year>2014</year><volume>35</volume><fpage>683</fpage><lpage>691</lpage><pub-id pub-id-type="doi">10.1093/carcin/bgt365</pub-id><pub-id pub-id-type="pmid">24282290</pub-id></element-citation></ref><ref id="B23-molecules-25-04435"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chapa</surname><given-names>J.J.D.L.</given-names></name><name><surname>Singha</surname><given-names>P.K.</given-names></name><name><surname>Lee</surname><given-names>D.R.</given-names></name><name><surname>Gonzales</surname><given-names>C.B.</given-names></name></person-group><article-title>Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis</article-title><source>J. Oral Pathol. Med.</source><year>2018</year><volume>47</volume><fpage>674</fpage><lpage>682</lpage><pub-id pub-id-type="doi">10.1111/jop.12735</pub-id><pub-id pub-id-type="pmid">29777637</pub-id></element-citation></ref><ref id="B24-molecules-25-04435"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dou</surname><given-names>J.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Ma</surname><given-names>L.</given-names></name><name><surname>Peng</surname><given-names>B.</given-names></name><name><surname>Mao</surname><given-names>K.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Su</surname><given-names>M.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Peng</surname><given-names>G.</given-names></name></person-group><article-title>Baicalein and baicalin inhibit colon cancer using two distinct fashions of apoptosis and senescence</article-title><source>Oncotarget</source><year>2018</year><volume>9</volume><fpage>20089</fpage><lpage>20102</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.24015</pub-id><pub-id pub-id-type="pmid">29732005</pub-id></element-citation></ref><ref id="B25-molecules-25-04435"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>Y.</given-names></name><name><surname>Zhan</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>G.</given-names></name><name><surname>Liang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>X.</given-names></name><name><surname>Shen</surname><given-names>H.</given-names></name></person-group><article-title>Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>14477</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-32734-2</pub-id><pub-id pub-id-type="pmid">30262902</pub-id></element-citation></ref><ref id="B26-molecules-25-04435"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname><given-names>Q.P.</given-names></name><name><surname>Wang</surname><given-names>M.J.</given-names></name><name><surname>Zeng</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>G.G.</given-names></name><name><surname>Huang</surname><given-names>R.Y.</given-names></name></person-group><article-title>Effects of Glycyrrhizin in a Mouse Model of Lung Adenocarcinoma</article-title><source>Cell. Physiol. Biochem.</source><year>2017</year><volume>41</volume><fpage>1383</fpage><lpage>1392</lpage><pub-id pub-id-type="doi">10.1159/000467897</pub-id><pub-id pub-id-type="pmid">28315871</pub-id></element-citation></ref><ref id="B27-molecules-25-04435"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhari</surname><given-names>A.S.</given-names></name><name><surname>Mandave</surname><given-names>P.C.</given-names></name><name><surname>Deshpande</surname><given-names>M.</given-names></name><name><surname>Ranjekar</surname><given-names>P.</given-names></name><name><surname>Prakash</surname><given-names>O.</given-names></name></person-group><article-title>Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice</article-title><source>Front. Pharmacol.</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.3389/fphar.2019.01614</pub-id></element-citation></ref><ref id="B28-molecules-25-04435"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Su</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Yu</surname><given-names>S.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Sun</surname><given-names>L.</given-names></name><name><surname>Yue</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>X.</given-names></name></person-group><article-title>Dicumarol inhibits PDK1 and targets multiple malignant behaviors of ovarian cancer cells</article-title><source>PLoS ONE</source><year>2017</year><volume>12</volume><elocation-id>e0179672</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0179672</pub-id><pub-id pub-id-type="pmid">28617852</pub-id></element-citation></ref><ref id="B29-molecules-25-04435"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>W.J.</given-names></name><name><surname>Wu</surname><given-names>G.J.</given-names></name><name><surname>Chen</surname><given-names>R.J.</given-names></name><name><surname>Chang</surname><given-names>C.C.</given-names></name><name><surname>Lien</surname><given-names>L.M.</given-names></name><name><surname>Chiu</surname><given-names>C.C.</given-names></name><name><surname>Tseng</surname><given-names>M.F.</given-names></name><name><surname>Huang</surname><given-names>L.T.</given-names></name><name><surname>Lin</surname><given-names>K.H.</given-names></name></person-group><article-title>Licochalcone A attenuates glioma cell growth in vitro and in vivo through cell cycle arrest</article-title><source>Food Funct.</source><year>2018</year><volume>9</volume><fpage>4500</fpage><lpage>4507</lpage><pub-id pub-id-type="doi">10.1039/C8FO00728D</pub-id><pub-id pub-id-type="pmid">30083664</pub-id></element-citation></ref><ref id="B30-molecules-25-04435"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Soto</surname><given-names>E.</given-names></name><name><surname>Estanislao-G&#x000f3;mez</surname><given-names>C.C.</given-names></name><name><surname>P&#x000e9;rez-Ishiwara</surname><given-names>D.G.</given-names></name><name><surname>Ramirez-Celis</surname><given-names>C.</given-names></name><name><surname>del Consuel G&#x000f3;mez-Garc&#x000ed;a</surname><given-names>M.</given-names></name></person-group><article-title>Cytotoxic Effect and Mechanisms from Some Plant-Derived Compounds in Breast Cancer</article-title><source>Cytotox. Defin. Identif. Cytotoxic Compd.</source><year>2019</year><fpage>1</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.5772/intechopen.87177</pub-id></element-citation></ref><ref id="B31-molecules-25-04435"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Ma</surname><given-names>Q.</given-names></name></person-group><article-title>Clinical benefits and pharmacology of scutellarin: A comprehensive review</article-title><source>Pharmacol. Ther.</source><year>2018</year><volume>190</volume><fpage>105</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2018.05.006</pub-id><pub-id pub-id-type="pmid">29742480</pub-id></element-citation></ref><ref id="B32-molecules-25-04435"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>S.</given-names></name></person-group><article-title>Scutellarin-induced apoptosis in HepG2 hepatocellular carcinoma cells via a STAT3 pathway</article-title><source>Phytother. Res.</source><year>2013</year><volume>27</volume><fpage>1524</fpage><lpage>1528</lpage><pub-id pub-id-type="doi">10.1002/ptr.4892</pub-id><pub-id pub-id-type="pmid">23192830</pub-id></element-citation></ref><ref id="B33-molecules-25-04435"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ke</surname><given-names>Y.</given-names></name><name><surname>Bao</surname><given-names>T.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>H.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Ge</surname><given-names>J.</given-names></name><name><surname>Fu</surname><given-names>B.</given-names></name><name><surname>Meng</surname><given-names>X.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2017</year><volume>483</volume><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2016.12.114</pub-id><pub-id pub-id-type="pmid">27998773</pub-id></element-citation></ref><ref id="B34-molecules-25-04435"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>N.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name></person-group><article-title>Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway</article-title><source>Mol. Med. Rep.</source><year>2017</year><volume>15</volume><fpage>929</fpage><lpage>935</lpage><pub-id pub-id-type="doi">10.3892/mmr.2016.6081</pub-id><pub-id pub-id-type="pmid">28035355</pub-id></element-citation></ref><ref id="B35-molecules-25-04435"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Fang</surname><given-names>L.</given-names></name></person-group><article-title>Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway</article-title><source>Med. Sci. Monit.</source><year>2017</year><volume>23</volume><fpage>5130</fpage><lpage>5138</lpage><pub-id pub-id-type="doi">10.12659/MSM.904492</pub-id><pub-id pub-id-type="pmid">29079722</pub-id></element-citation></ref><ref id="B36-molecules-25-04435"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mahmood</surname><given-names>A.</given-names></name></person-group><article-title>Isolation, synthesis and pharmacological applications of cirsimaritin&#x02014;A short review</article-title><source>Acad. J. Med. Plants</source><year>2019</year><volume>7</volume><fpage>252</fpage><lpage>260</lpage><pub-id pub-id-type="doi">10.15413/ajmp.2019.0159</pub-id></element-citation></ref><ref id="B37-molecules-25-04435"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>G.</given-names></name><name><surname>Singh</surname><given-names>S.</given-names></name><name><surname>Kumari</surname><given-names>P.</given-names></name><name><surname>Raza</surname><given-names>W.</given-names></name><name><surname>Hussain</surname><given-names>Y.</given-names></name><name><surname>Meena</surname><given-names>A.</given-names></name></person-group><article-title>Cirsimaritin, a lung squamous carcinoma cells (NCIH-520) proliferation inhibitor</article-title><source>J. Biomol. Struct. Dyn.</source><year>2020</year><volume>0</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1080/07391102.2020.1763198</pub-id></element-citation></ref><ref id="B38-molecules-25-04435"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yeon</surname><given-names>J.</given-names></name><name><surname>Young</surname><given-names>H.</given-names></name><name><surname>Shibamoto</surname><given-names>T.</given-names></name><name><surname>Su</surname><given-names>T.</given-names></name><name><surname>Cheon</surname><given-names>S.</given-names></name><name><surname>Suk</surname><given-names>J.</given-names></name><name><surname>Hahm</surname><given-names>D.H.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Sung</surname><given-names>K.</given-names></name></person-group><article-title>Beneficial effects of a medicinal herb, <italic>Cirsium japonicum</italic> var. maackii, extract and its major component, cirsimaritin on breast cancer metastasis in MDA-MB-231 breast cancer cells</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2017</year><volume>27</volume><fpage>3968</fpage><lpage>3973</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2017.07.070</pub-id><pub-id pub-id-type="pmid">28784292</pub-id></element-citation></ref><ref id="B39-molecules-25-04435"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quan</surname><given-names>Z.</given-names></name><name><surname>Gu</surname><given-names>J.</given-names></name><name><surname>Dong</surname><given-names>P.</given-names></name><name><surname>Lu</surname><given-names>J.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>W.</given-names></name><name><surname>Fei</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells</article-title><source>Cancer Lett.</source><year>2010</year><volume>295</volume><fpage>252</fpage><lpage>259</lpage><pub-id pub-id-type="doi">10.1016/j.canlet.2010.03.008</pub-id><pub-id pub-id-type="pmid">20359814</pub-id></element-citation></ref><ref id="B40-molecules-25-04435"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aburjai</surname><given-names>T.A.</given-names></name><name><surname>Mansi</surname><given-names>K.</given-names></name><name><surname>Azzam</surname><given-names>H.</given-names></name><name><surname>Alqudah</surname><given-names>D.A.</given-names></name><name><surname>Alshaer</surname><given-names>W.</given-names></name><name><surname>Abuirjei</surname><given-names>M.</given-names></name></person-group><article-title>Chemical Compositions and Anticancer Potential of &#x02018;Essential Oil from Greenhouse-cultivated Ocimum basilicum Leaves</article-title><source>Indian J. Pharm. Sci.</source><year>2020</year><volume>82</volume><fpage>179</fpage><lpage>184</lpage><pub-id pub-id-type="doi">10.36468/pharmaceutical-sciences.637</pub-id></element-citation></ref><ref id="B41-molecules-25-04435"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Afoulous</surname><given-names>S.</given-names></name><name><surname>Ferhout</surname><given-names>H.</given-names></name><name><surname>Raoelison</surname><given-names>E.G.</given-names></name><name><surname>Valentin</surname><given-names>A.</given-names></name><name><surname>Moukarzel</surname><given-names>B.</given-names></name><name><surname>Couderc</surname><given-names>F.</given-names></name><name><surname>Bouajila</surname><given-names>J.</given-names></name></person-group><article-title>Chemical composition and anticancer, antiinflammatory, antioxidant and antimalarial activities of leaves essential oil of Cedrelopsis grevei</article-title><source>Food Chem. Toxicol.</source><year>2013</year><volume>56</volume><fpage>352</fpage><lpage>362</lpage><pub-id pub-id-type="doi">10.1016/j.fct.2013.02.008</pub-id><pub-id pub-id-type="pmid">23459148</pub-id></element-citation></ref><ref id="B42-molecules-25-04435"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomko</surname><given-names>A.M.</given-names></name><name><surname>Whynot</surname><given-names>E.G.</given-names></name><name><surname>Ellis</surname><given-names>L.D.</given-names></name><name><surname>Dupr&#x000e9;</surname><given-names>D.J.</given-names></name></person-group><article-title>Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis</article-title><source>Cancers</source><year>2020</year><volume>12</volume><elocation-id>1985</elocation-id><pub-id pub-id-type="doi">10.3390/cancers12071985</pub-id><?supplied-pmid 32708138?><pub-id pub-id-type="pmid">32708138</pub-id></element-citation></ref><ref id="B43-molecules-25-04435"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Janganati</surname><given-names>V.</given-names></name><name><surname>Ponder</surname><given-names>J.</given-names></name><name><surname>Balasubramaniam</surname><given-names>M.</given-names></name><name><surname>Bhat-Nakshatri</surname><given-names>P.</given-names></name><name><surname>Bar</surname><given-names>E.E.</given-names></name><name><surname>Nakshatri</surname><given-names>H.</given-names></name><name><surname>Jordan</surname><given-names>C.T.</given-names></name><name><surname>Crooks</surname><given-names>P.A.</given-names></name></person-group><article-title>MMB triazole analogs are potent NF-&#x003ba;B inhibitors and anti-cancer agents against both hematological and solid tumor cells</article-title><source>Eur. J. Med. Chem.</source><year>2018</year><volume>157</volume><fpage>562</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2018.08.010</pub-id><?supplied-pmid 30121494?><pub-id pub-id-type="pmid">30121494</pub-id></element-citation></ref><ref id="B44-molecules-25-04435"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ambavade</surname><given-names>S.D.</given-names></name><name><surname>Misar</surname><given-names>A.V.</given-names></name><name><surname>Ambavade</surname><given-names>P.D.</given-names></name></person-group><article-title>Pharmacological, nutritional, and analytical aspects of &#x003b2;-sitosterol: A review</article-title><source>Orient Pharm Exp. Med.</source><year>2014</year><volume>14</volume><fpage>193</fpage><lpage>211</lpage><pub-id pub-id-type="doi">10.1007/s13596-014-0151-9</pub-id></element-citation></ref><ref id="B45-molecules-25-04435"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>E.J.</given-names></name><name><surname>Choi</surname><given-names>H.K.</given-names></name><name><surname>Sung</surname><given-names>M.J.</given-names></name><name><surname>Park</surname><given-names>J.H.</given-names></name><name><surname>Chung</surname><given-names>M.Y.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Hwang</surname><given-names>J.T.</given-names></name></person-group><article-title>Anti-tumour effects of beta-sitosterol are mediated by AMPK/PTEN/HSP90 axis in AGS human gastric adenocarcinoma cells and xenograft mouse models</article-title><source>Biochem. Pharm.</source><year>2018</year><volume>152</volume><fpage>60</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/j.bcp.2018.03.010</pub-id><?supplied-pmid 29559312?><pub-id pub-id-type="pmid">29559312</pub-id></element-citation></ref><ref id="B46-molecules-25-04435"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajavel</surname><given-names>T.</given-names></name><name><surname>Packiyaraj</surname><given-names>P.</given-names></name><name><surname>Suryanarayanan</surname><given-names>V.</given-names></name><name><surname>Singh</surname><given-names>S.K.</given-names></name><name><surname>Ruckmani</surname><given-names>K.</given-names></name><name><surname>Pandima Devi</surname><given-names>K.</given-names></name></person-group><article-title>&#x003b2;-Sitosterol targets Trx/Trx1 reductase to induce apoptosis in A549 cells via ROS mediated mitochondrial dysregulation and p53 activation</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>2071</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-20311-6</pub-id><pub-id pub-id-type="pmid">29391428</pub-id></element-citation></ref><ref id="B47-molecules-25-04435"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Ma</surname><given-names>Z.</given-names></name><name><surname>Shi</surname><given-names>A.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name><name><surname>Song</surname><given-names>Y.</given-names></name></person-group><article-title>&#x003b2;-Sitosterol and Gemcitabine Exhibit Synergistic Anti-pancreatic Cancer Activity by Modulating Apoptosis and Inhibiting Epithelial&#x02013;Mesenchymal Transition by Deactivating Akt/GSK-3&#x003b2; Signaling</article-title><source>Front. Pharmacol.</source><year>2019</year><fpage>9</fpage><pub-id pub-id-type="doi">10.3389/fphar.2018.01525</pub-id><?supplied-pmid 30670971?><pub-id pub-id-type="pmid">30837865</pub-id></element-citation></ref><ref id="B48-molecules-25-04435"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Yuan</surname><given-names>J.</given-names></name><name><surname>Hao</surname><given-names>J.</given-names></name><name><surname>Wen</surname><given-names>Y.</given-names></name><name><surname>Lv</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Yang</surname><given-names>X.</given-names></name></person-group><article-title>&#x003b1;-Humulene inhibits hepatocellular carcinoma cell proliferation and induces apoptosis through the inhibition of Akt signaling</article-title><source>Food Chem. Toxicol.</source><year>2019</year><volume>134</volume><fpage>110830</fpage><pub-id pub-id-type="doi">10.1016/j.fct.2019.110830</pub-id><pub-id pub-id-type="pmid">31562948</pub-id></element-citation></ref><ref id="B49-molecules-25-04435"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Greenwell</surname><given-names>M.</given-names></name><name><surname>Rahman</surname><given-names>P.K.S.M.</given-names></name></person-group><article-title>Medicinal Plants: Their Use in Anticancer Treatment</article-title><source>Int. J. Pharm. Sci. Res.</source><year>2015</year><volume>6</volume><fpage>4103</fpage><lpage>4112</lpage><pub-id pub-id-type="doi">10.13040/IJPSR.0975-8232.6(10).4103-12</pub-id><pub-id pub-id-type="pmid">26594645</pub-id></element-citation></ref><ref id="B50-molecules-25-04435"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigham</surname><given-names>C.</given-names></name></person-group><article-title>Perspectives for the biotechnological production of biofuels from CO<sub>2</sub> and H<sub>2</sub> using Ralstonia eutropha and other &#x02018;Knallgas&#x02019; bacteria</article-title><source>Appl. Microbiol. Biotechnol.</source><year>2019</year><volume>103</volume><fpage>2113</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1007/s00253-019-09636-y</pub-id><pub-id pub-id-type="pmid">30666363</pub-id></element-citation></ref><ref id="B51-molecules-25-04435"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsunaga</surname><given-names>S.N.</given-names></name><name><surname>Mochizuki</surname><given-names>T.</given-names></name><name><surname>Ohno</surname><given-names>T.</given-names></name><name><surname>Endo</surname><given-names>Y.</given-names></name><name><surname>Kusumoto</surname><given-names>D.</given-names></name><name><surname>Tani</surname><given-names>A.</given-names></name></person-group><article-title>Monoterpene and sesquiterpene emissions from Sugi (<italic>Cryptomeria japonica</italic>) based on a branch enclosure measurements</article-title><source>Atmos. Pollut. Res.</source><year>2011</year><volume>2</volume><fpage>16</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.5094/APR.2011.003</pub-id></element-citation></ref><ref id="B52-molecules-25-04435"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peter</surname><given-names>S.R.</given-names></name><name><surname>Peru</surname><given-names>K.M.</given-names></name><name><surname>Fahlman</surname><given-names>B.</given-names></name><name><surname>McMartin</surname><given-names>D.W.</given-names></name><name><surname>Headley</surname><given-names>J.V.</given-names></name></person-group><article-title>The application of HPLC ESI MS in the investigation of the flavonoids and flavonoid glycosides of a Caribbean Lamiaceae plant with potential for bioaccumulation</article-title><source>J. Environ. Sci. Health Part B</source><year>2015</year><volume>50</volume><fpage>819</fpage><lpage>826</lpage><pub-id pub-id-type="doi">10.1080/03601234.2015.1058103</pub-id><?supplied-pmid 26357892?><pub-id pub-id-type="pmid">26357892</pub-id></element-citation></ref><ref id="B53-molecules-25-04435"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shafiq</surname><given-names>A.</given-names></name><name><surname>Moore</surname><given-names>J.</given-names></name><name><surname>Suleman</surname><given-names>A.</given-names></name><name><surname>Faiz</surname><given-names>S.</given-names></name><name><surname>Farooq</surname><given-names>O.</given-names></name><name><surname>Arshad</surname><given-names>A.</given-names></name><name><surname>Tehseen</surname><given-names>M.</given-names></name><name><surname>Zafar</surname><given-names>A.</given-names></name><name><surname>Ali</surname><given-names>S.H.</given-names></name><name><surname>Din</surname><given-names>N.U.</given-names></name><etal/></person-group><article-title>Elevated Soluble Galectin-3 as a Marker of Chemotherapy Efficacy in Breast Cancer Patients: A Prospective Study</article-title><source>Int. J. Breast Cancer</source><year>2020</year><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1155/2020/4824813</pub-id><?supplied-pmid 32231800?><pub-id pub-id-type="pmid">32231800</pub-id></element-citation></ref><ref id="B54-molecules-25-04435"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edilu</surname><given-names>A.</given-names></name><name><surname>Adane</surname><given-names>L.</given-names></name><name><surname>Woyessa</surname><given-names>D.</given-names></name></person-group><article-title>In vitro antibacterial activities of compounds isolated from roots of Caylusea abyssinica</article-title><source>Ann. Clin. Microbiol. Antimicrob.</source><year>2015</year><volume>14</volume><fpage>15</fpage><pub-id pub-id-type="doi">10.1186/s12941-015-0072-6</pub-id><?supplied-pmid 25858449?><pub-id pub-id-type="pmid">25858449</pub-id></element-citation></ref><ref id="B55-molecules-25-04435"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Zafar</surname><given-names>R.</given-names></name></person-group><article-title>Occurrence of Taraxerol and Taraxasterol in Medicinal Plants</article-title><source>Pharmacogn. Rev.</source><year>2015</year><volume>9</volume><fpage>19</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">26009688</pub-id></element-citation></ref><ref id="B56-molecules-25-04435"><label>56.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Magdalena</surname><given-names>M.</given-names></name><name><surname>El&#x0017c;bieta</surname><given-names>S.</given-names></name><name><surname>Jan</surname><given-names>O.</given-names></name></person-group><source>Lipophilicity of Lupeol Semisynthetic Derivates</source><publisher-name>Wydawnictwo Uniwersytetu Ekonomicznego we Wroc&#x00142;awiu</publisher-name><publisher-loc>Wroc&#x00142;aw, Poland</publisher-loc><year>2015</year><fpage>97</fpage><lpage>103</lpage></element-citation></ref><ref id="B57-molecules-25-04435"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>E.</given-names></name><name><surname>Teixeira</surname><given-names>J.</given-names></name><name><surname>Silva</surname><given-names>D.</given-names></name><name><surname>dos Santos</surname><given-names>T.</given-names></name><name><surname>Korn</surname><given-names>M.</given-names></name><name><surname>Brand&#x000e3;o</surname><given-names>H.</given-names></name><name><surname>Ferraz</surname><given-names>C.</given-names></name><name><surname>Meira</surname><given-names>C.</given-names></name><name><surname>Soares</surname><given-names>M.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Phytochemical Analysis, Multi-Element Composition and Biological Activities of Extracts and Lupenone from Albizia inundata (Mart.) Barneby &#x00026; J.W.Grimes</article-title><source>J. Braz. Chem. Soc.</source><year>2020</year><volume>00</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.21577/0103-5053.20200069</pub-id></element-citation></ref><ref id="B58-molecules-25-04435"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balogun</surname><given-names>F.</given-names></name><name><surname>Ashafa</surname><given-names>A.</given-names></name></person-group><article-title>Antioxidant and hepatoprotective activities of <italic>Dicoma anomala</italic> Sond. aqueous root extract against carbon tetrachloride-induced liver damage in Wistar rats</article-title><source>J. Tradit. Chin. Med.</source><year>2016</year><volume>36</volume><fpage>504</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0254-6272(16)30068-1</pub-id><pub-id pub-id-type="pmid">28459518</pub-id></element-citation></ref><ref id="B59-molecules-25-04435"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Becker</surname><given-names>J.V.</given-names></name><name><surname>van der Merwe</surname><given-names>M.M.</given-names></name><name><surname>van Brummelen</surname><given-names>A.C.</given-names></name><name><surname>Pillay</surname><given-names>P.</given-names></name><name><surname>Crampton</surname><given-names>B.G.</given-names></name><name><surname>Mmutlane</surname><given-names>E.M.</given-names></name><name><surname>Parkinson</surname><given-names>C.</given-names></name><name><surname>van Heerden</surname><given-names>F.R.</given-names></name><name><surname>Crouch</surname><given-names>N.R.</given-names></name><name><surname>Smith</surname><given-names>P.J.</given-names></name><etal/></person-group><article-title>In vitro anti-plasmodial activity of <italic>Dicoma anomala</italic> subsp. gerrardii (Asteraceae): Identification of its main active constituent, structure-activity relationship studies and gene expression profiling</article-title><source>Malar. J.</source><year>2011</year><volume>10</volume><fpage>295</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-10-295</pub-id><pub-id pub-id-type="pmid">21985233</pub-id></element-citation></ref><ref id="B60-molecules-25-04435"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asita</surname><given-names>A.</given-names></name><name><surname>Heisi</surname><given-names>D.</given-names></name><name><surname>Tjale</surname><given-names>T.</given-names></name></person-group><article-title>Modulation of Mutagen-Induced Genotoxicity by two Lesotho Medicinal Plants in <italic>Allium cepa</italic> L.</article-title><source>Environ. Nat. Resour. Res.</source><year>2015</year><volume>5</volume><fpage>37</fpage><pub-id pub-id-type="doi">10.5539/enrr.v5n3p37</pub-id></element-citation></ref><ref id="B61-molecules-25-04435"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balogun</surname><given-names>F.O.</given-names></name><name><surname>Ashafa</surname><given-names>A.O.T.</given-names></name></person-group><article-title>Comparative study on the antioxidant activity of <italic>Dicoma anomala</italic> and Gazania krebsiana used in Basotho traditional medicine</article-title><source>S. Afr. J. Bot.</source><year>2015</year><volume>98</volume><fpage>170</fpage><pub-id pub-id-type="doi">10.1016/j.sajb.2015.03.014</pub-id></element-citation></ref><ref id="B62-molecules-25-04435"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choudhery</surname><given-names>M.S.</given-names></name><name><surname>Harris</surname><given-names>D.T.</given-names></name></person-group><article-title>Stem cell therapy for COVID-19: Possibilities and challenges</article-title><source>Cell Biol. Int.</source><year>2020</year><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1002/cbin.11440</pub-id></element-citation></ref><ref id="B63-molecules-25-04435"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zakrzewski</surname><given-names>W.</given-names></name><name><surname>Dobrzy&#x00144;ski</surname><given-names>M.</given-names></name><name><surname>Szymonowicz</surname><given-names>M.</given-names></name><name><surname>Rybak</surname><given-names>Z.</given-names></name></person-group><article-title>Stem cells: Past, present, and future</article-title><source>Stem Cell Res. Ther.</source><year>2019</year><volume>10</volume><fpage>68</fpage><pub-id pub-id-type="doi">10.1186/s13287-019-1165-5</pub-id><?supplied-pmid 30808416?><pub-id pub-id-type="pmid">30808416</pub-id></element-citation></ref><ref id="B64-molecules-25-04435"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ratajczak</surname><given-names>M.Z.</given-names></name><name><surname>Ciechanowicz</surname><given-names>A.K.</given-names></name><name><surname>Kucharska-Mazur</surname><given-names>J.</given-names></name><name><surname>Samochowiec</surname><given-names>J.</given-names></name></person-group><article-title>Stem cells and their potential clinical applications in psychiatric disorders</article-title><source>Prog Neuropsychopharmacol Biol Psychiatry</source><year>2018</year><volume>80</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.pnpbp.2017.04.020</pub-id><?supplied-pmid 28435007?><pub-id pub-id-type="pmid">28435007</pub-id></element-citation></ref><ref id="B65-molecules-25-04435"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>Y.J.</given-names></name><name><surname>Siegler</surname><given-names>E.L.</given-names></name><name><surname>Siriwon</surname><given-names>N.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name></person-group><article-title>Therapeutic strategies for targeting cancer stem cells</article-title><source>J. Cancer Metastasis Treat.</source><year>2016</year><volume>2</volume><fpage>233</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.20517/2394-4722.2016.26</pub-id></element-citation></ref><ref id="B66-molecules-25-04435"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagai</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>Y.H.</given-names></name></person-group><article-title>Cancer prevention from the perspective of global cancer burden patterns</article-title><source>J. Thorac. Dis.</source><year>2017</year><volume>9</volume><fpage>448</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.21037/jtd.2017.02.75</pub-id><pub-id pub-id-type="pmid">28449441</pub-id></element-citation></ref><ref id="B67-molecules-25-04435"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaikh</surname><given-names>R.</given-names></name><name><surname>Pund</surname><given-names>M.</given-names></name><name><surname>Dawane</surname><given-names>A.</given-names></name><name><surname>Iliyas</surname><given-names>S.</given-names></name></person-group><article-title>Evaluation of Anticancer, Antioxidant, and Possible Anti-inflammatory Properties of Selected Medicinal Plants Used in Indian Traditional Medication</article-title><source>J. Tradit. Complement. Med.</source><year>2014</year><volume>4</volume><fpage>253</fpage><lpage>257</lpage><pub-id pub-id-type="doi">10.4103/2225-4110.128904</pub-id><pub-id pub-id-type="pmid">25379467</pub-id></element-citation></ref><ref id="B68-molecules-25-04435"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akbari</surname><given-names>M.E.</given-names></name><name><surname>Khayamzadeh</surname><given-names>M.</given-names></name><name><surname>Mirzaei</surname><given-names>H.R.</given-names></name><name><surname>Moradi</surname><given-names>A.</given-names></name><name><surname>Akbari</surname><given-names>A.</given-names></name><name><surname>Moradian</surname><given-names>F.</given-names></name><name><surname>Khalili</surname><given-names>N.</given-names></name></person-group><article-title>Saving the Breast Saves the Lives of Breast Cancer Patients</article-title><source>Int. J. Surg. Oncol.</source><year>2020</year><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1155/2020/8709231</pub-id></element-citation></ref><ref id="B69-molecules-25-04435"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSantis</surname><given-names>C.E.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><name><surname>Gaudet</surname><given-names>M.M.</given-names></name><name><surname>Newman</surname><given-names>L.A.</given-names></name><name><surname>Miller</surname><given-names>K.D.</given-names></name><name><surname>Sauer</surname><given-names>A.G.</given-names></name><name><surname>Jemal</surname><given-names>A.</given-names></name><name><surname>Siegel</surname><given-names>R.L.</given-names></name></person-group><article-title>Breast cancer statistics, 2019</article-title><source>CA Cancer J. Clin.</source><year>2019</year><volume>69</volume><fpage>438</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.3322/caac.21583</pub-id><pub-id pub-id-type="pmid">31577379</pub-id></element-citation></ref><ref id="B70-molecules-25-04435"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>G.N.</given-names></name><name><surname>Dave</surname><given-names>R.</given-names></name><name><surname>Sanadya</surname><given-names>J.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Sharma</surname><given-names>K.K.</given-names></name></person-group><article-title>Various Types and Management of Breast Cancer: An Overview</article-title><source>J. Adv. Pharm. Technol. Res.</source><year>2010</year><volume>1</volume><fpage>109</fpage><lpage>126</lpage><pub-id pub-id-type="pmid">22247839</pub-id></element-citation></ref><ref id="B71-molecules-25-04435"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Street</surname><given-names>W.</given-names></name></person-group><article-title>Breast Cancer Facts &#x00026; Figures 2019&#x02013;2020</article-title><source>Am. Cancer Soc.</source><year>2019</year><fpage>1</fpage><lpage>38</lpage></element-citation></ref><ref id="B72-molecules-25-04435"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y.S.</given-names></name><name><surname>Zhao</surname><given-names>Z.</given-names></name><name><surname>Yang</surname><given-names>Z.N.</given-names></name><name><surname>Xu</surname><given-names>F.</given-names></name><name><surname>Lu</surname><given-names>H.J.</given-names></name><name><surname>Zhu</surname><given-names>Z.Y.</given-names></name><name><surname>Shi</surname><given-names>W.</given-names></name><name><surname>Jiang</surname><given-names>J.</given-names></name><name><surname>Yao</surname><given-names>P.P.</given-names></name><name><surname>Zhu</surname><given-names>H.P.</given-names></name></person-group><article-title>Risk Factors and Preventions of Breast Cancer</article-title><source>Int. J. Biol. Sci.</source><year>2017</year><volume>13</volume><fpage>1387</fpage><lpage>1397</lpage><pub-id pub-id-type="doi">10.7150/ijbs.21635</pub-id><pub-id pub-id-type="pmid">29209143</pub-id></element-citation></ref><ref id="B73-molecules-25-04435"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>E.S.</given-names></name><name><surname>Clark</surname><given-names>A.S.</given-names></name><name><surname>Tchou</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Freedman</surname><given-names>G.M.</given-names></name></person-group><article-title>Clinical Diagnosis and Management of Breast Cancer</article-title><source>J. Nucl. Med.</source><year>2016</year><volume>57</volume><fpage>9S</fpage><lpage>16S</lpage><pub-id pub-id-type="doi">10.2967/jnumed.115.157834</pub-id><?supplied-pmid 26834110?><pub-id pub-id-type="pmid">26834110</pub-id></element-citation></ref><ref id="B74-molecules-25-04435"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>J.</given-names></name><name><surname>Malvezzi</surname><given-names>M.</given-names></name><name><surname>Negri</surname><given-names>E.</given-names></name><name><surname>Vecchia</surname><given-names>C.L.</given-names></name><name><surname>Boffetta</surname><given-names>P.</given-names></name></person-group><article-title>Risk factors for lung cancer worldwide</article-title><source>Eur. Respir. J.</source><year>2016</year><volume>48</volume><fpage>889</fpage><lpage>902</lpage><pub-id pub-id-type="doi">10.1183/13993003.00359-2016</pub-id><?supplied-pmid 27174888?><pub-id pub-id-type="pmid">27174888</pub-id></element-citation></ref><ref id="B75-molecules-25-04435"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Latimer</surname><given-names>K.</given-names></name><name><surname>Mott</surname><given-names>T.</given-names></name></person-group><article-title>Lung Cancer: Diagnosis, Treatment Principles, and Screening</article-title><source>Am. Fam. Physician</source><year>2015</year><volume>91</volume><fpage>250</fpage><lpage>256</lpage><?supplied-pmid 25955626?><pub-id pub-id-type="pmid">25955626</pub-id></element-citation></ref><ref id="B76-molecules-25-04435"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Groot</surname><given-names>P.M.</given-names></name><name><surname>Wu</surname><given-names>C.C.</given-names></name><name><surname>Carter</surname><given-names>B.W.</given-names></name><name><surname>Munden</surname><given-names>R.F.</given-names></name></person-group><article-title>The epidemiology of lung cancer</article-title><source>Transl. Lung Cancer Res.</source><year>2018</year><volume>7</volume><fpage>220</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.21037/tlcr.2018.05.06</pub-id><?supplied-pmid 30050761?><pub-id pub-id-type="pmid">30050761</pub-id></element-citation></ref><ref id="B77-molecules-25-04435"><label>77.</label><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Edward</surname><given-names>B.</given-names></name><name><surname>Garon</surname><given-names>M.D.</given-names></name></person-group><article-title>Staging of Non&#x02013;Small-Cell Lung Cancer: A Guide Patients</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://conquer-magazine.com/issues/2020/vol-6-no-1-february-2020/1203-staging-of-non-small-cell-lung-cancer-a-guide-for-patients">https://conquer-magazine.com/issues/2020/vol-6-no-1-february-2020/1203-staging-of-non-small-cell-lung-cancer-a-guide-for-patients</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-08-24">(accessed on 24 August 2020)</date-in-citation></element-citation></ref><ref id="B78-molecules-25-04435"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstraw</surname><given-names>P.</given-names></name><name><surname>Chansky</surname><given-names>K.</given-names></name><name><surname>Crowley</surname><given-names>J.</given-names></name><name><surname>Ramiporta</surname><given-names>R.</given-names></name><name><surname>Asamura</surname><given-names>H.</given-names></name><name><surname>Eberhardt</surname><given-names>W.</given-names></name><name><surname>Nicholson</surname><given-names>A.G.</given-names></name><name><surname>Groome</surname><given-names>P.</given-names></name><name><surname>Mitchell</surname><given-names>A.</given-names></name><name><surname>Bolejack</surname><given-names>V.</given-names></name></person-group><article-title>The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer</article-title><source>J. Thorac. Oncol.</source><year>2016</year><volume>11</volume><fpage>39</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.jtho.2015.09.009</pub-id><?supplied-pmid 26762738?><pub-id pub-id-type="pmid">26762738</pub-id></element-citation></ref><ref id="B79-molecules-25-04435"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name></person-group><article-title>Emerging therapies for small cell lung cancer</article-title><source>J. Hematol. Oncol.</source><year>2019</year><volume>12</volume><fpage>47</fpage><pub-id pub-id-type="doi">10.1186/s13045-019-0736-3</pub-id><pub-id pub-id-type="pmid">31046803</pub-id></element-citation></ref><ref id="B80-molecules-25-04435"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rawla</surname><given-names>P.</given-names></name><name><surname>Sunkara</surname><given-names>T.</given-names></name><name><surname>Barsouk</surname><given-names>A.</given-names></name></person-group><article-title>Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors</article-title><source>Przegl&#x00061;&#x0031c;d Gastroenterol.</source><year>2019</year><volume>14</volume><fpage>89</fpage><pub-id pub-id-type="doi">10.5114/pg.2018.81072</pub-id></element-citation></ref><ref id="B81-molecules-25-04435"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuipers</surname><given-names>E.J.</given-names></name><name><surname>Grady</surname><given-names>W.M.</given-names></name><name><surname>Lieberman</surname><given-names>D.</given-names></name><name><surname>Seufferlein</surname><given-names>T.</given-names></name><name><surname>Sung</surname><given-names>J.J.</given-names></name><name><surname>Boelens</surname><given-names>P.G.</given-names></name><name><surname>van de Velde</surname><given-names>C.J.H.</given-names></name><name><surname>Watanabe</surname><given-names>T.</given-names></name></person-group><article-title>Colorectal cancer</article-title><source>Nat. Rev. Dis Primers</source><year>2015</year><volume>1</volume><fpage>15065</fpage><pub-id pub-id-type="doi">10.1038/nrdp.2015.65</pub-id><pub-id pub-id-type="pmid">27189416</pub-id></element-citation></ref><ref id="B82-molecules-25-04435"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kekelidze</surname><given-names>M.</given-names></name><name><surname>D&#x02019;Errico</surname><given-names>L.</given-names></name><name><surname>Pansini</surname><given-names>M.</given-names></name><name><surname>Tyndall</surname><given-names>A.</given-names></name><name><surname>Hohmann</surname><given-names>J.</given-names></name></person-group><article-title>Colorectal cancer: Current imaging methods and future perspectives for the diagnosis, staging and therapeutic response evaluation</article-title><source>World J. Gastroenterol.</source><year>2013</year><volume>19</volume><fpage>8502</fpage><lpage>8514</lpage><pub-id pub-id-type="doi">10.3748/wjg.v19.i46.8502</pub-id><pub-id pub-id-type="pmid">24379567</pub-id></element-citation></ref><ref id="B83-molecules-25-04435"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merriel</surname><given-names>S.W.D.</given-names></name><name><surname>Funston</surname><given-names>G.</given-names></name><name><surname>Hamilton</surname><given-names>W.</given-names></name></person-group><article-title>Prostate Cancer in Primary Care</article-title><source>Adv. Ther.</source><year>2018</year><volume>35</volume><fpage>1285</fpage><lpage>1294</lpage><pub-id pub-id-type="doi">10.1007/s12325-018-0766-1</pub-id><pub-id pub-id-type="pmid">30097885</pub-id></element-citation></ref><ref id="B84-molecules-25-04435"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>US Preventive Services Task Force</collab><name><surname>Grossman</surname><given-names>D.C.</given-names></name><name><surname>Curry</surname><given-names>S.J.</given-names></name><name><surname>Owens</surname><given-names>D.K.</given-names></name><name><surname>Bibbins-Domingo</surname><given-names>K.</given-names></name><name><surname>Caughey</surname><given-names>A.B.</given-names></name><name><surname>Davidson</surname><given-names>K.W.</given-names></name><name><surname>Doubeni</surname><given-names>C.A.</given-names></name><name><surname>Ebell</surname><given-names>M.</given-names></name><name><surname>Epling</surname><given-names>J.W.</given-names></name><etal/></person-group><article-title>Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement</article-title><source>JAMA</source><year>2018</year><volume>319</volume><fpage>1901</fpage><lpage>1913</lpage><pub-id pub-id-type="doi">10.1001/jama.2018.3710</pub-id><?supplied-pmid 29801017?><pub-id pub-id-type="pmid">29801017</pub-id></element-citation></ref><ref id="B85-molecules-25-04435"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gasnier</surname><given-names>A.</given-names></name><name><surname>Parvizi</surname><given-names>N.</given-names></name></person-group><article-title>Updates on the diagnosis and treatment of prostate cancer</article-title><source>Br. J. Radiol</source><year>2017</year><fpage>90</fpage><pub-id pub-id-type="doi">10.1259/bjr.20170180</pub-id><?supplied-pmid 28555500?><pub-id pub-id-type="pmid">28555500</pub-id></element-citation></ref><ref id="B86-molecules-25-04435"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>E.</given-names></name><name><surname>Arshad</surname><given-names>M.</given-names></name><name><surname>Khan</surname><given-names>M.Z.</given-names></name><name><surname>Amjad</surname><given-names>M.S.</given-names></name><name><surname>Sadaf</surname><given-names>H.M.</given-names></name><name><surname>Riaz</surname><given-names>I.</given-names></name><name><surname>Ahmad</surname><given-names>N.</given-names></name></person-group><article-title>Secondary metabolites and their multidimensional prospective in plant life</article-title><source>J. Pharmacogn. Phytochem.</source><year>2017</year><volume>6</volume><fpage>205</fpage><lpage>214</lpage></element-citation></ref><ref id="B87-molecules-25-04435"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>R.</given-names></name><name><surname>Mirza</surname><given-names>Z.</given-names></name><name><surname>Ashraf</surname><given-names>G.M.D.</given-names></name><name><surname>Kamal</surname><given-names>M.A.</given-names></name><name><surname>Ansari</surname><given-names>S.A.</given-names></name><name><surname>Damanhouri</surname><given-names>G.A.</given-names></name><name><surname>Abuzenadah</surname><given-names>A.M.</given-names></name><name><surname>Chaudhary</surname><given-names>A.G.</given-names></name><name><surname>Sheikh</surname><given-names>I.A.</given-names></name></person-group><article-title>New anticancer agents: Recent developments in tumor therapy</article-title><source>Anticancer Res.</source><volume>2012. 32</volume><fpage>2999</fpage><lpage>3005</lpage></element-citation></ref><ref id="B88-molecules-25-04435"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palmer</surname><given-names>A.C.</given-names></name><name><surname>Sorger</surname><given-names>P.K.</given-names></name></person-group><article-title>Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy</article-title><source>Cell</source><year>2017</year><volume>171</volume><fpage>1678</fpage><lpage>1691</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2017.11.009</pub-id><pub-id pub-id-type="pmid">29245013</pub-id></element-citation></ref><ref id="B89-molecules-25-04435"><label>89.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Neutel</surname><given-names>J.</given-names></name></person-group><article-title>Advantages of Combination Therapy Compared with Monotherapy</article-title><source>Combination Therapy in Hypertension</source><person-group person-group-type="editor"><name><surname>Neutel</surname><given-names>J.M.</given-names></name></person-group><publisher-name>Springer Healthcare Ltd.</publisher-name><publisher-loc>Tarporley, UK</publisher-loc><year>2011</year><pub-id pub-id-type="doi">10.1007/978-1-908517-28-9_3</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="molecules-25-04435-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p><italic>Dicoma anomala</italic> habitat. <italic>Dicoma anomala</italic> plant from eastern province of Zambia.</p></caption><graphic xlink:href="molecules-25-04435-g001"/></fig><fig id="molecules-25-04435-f002" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Carcinogenesis and the mechanism of action through which plant-derived bioactive compounds induce cell death.</p></caption><graphic xlink:href="molecules-25-04435-g002"/></fig><fig id="molecules-25-04435-f003" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Possible mechanisms of action induced by plant-derived phytochemicals.</p></caption><graphic xlink:href="molecules-25-04435-g003"/></fig><fig id="molecules-25-04435-f004" orientation="portrait" position="float"><label>Figure 4</label><caption><p>General cell death signaling pathways induced by plant-derived bioactive compounds.</p></caption><graphic xlink:href="molecules-25-04435-g004"/></fig><table-wrap id="molecules-25-04435-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04435-t001_Table 1</object-id><label>Table 1</label><caption><p>Shows the general taxonomy and common <italic>Dicoma</italic> species.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Kingdom</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phylum</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Class</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Order</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Family</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Genus</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Species</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Plantae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Magnoliophyta</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Magnoliopsida</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asterale</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asteraceae</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Dicoma</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>
<italic>anomala</italic>
</p></list-item><list-item><p>
<italic>arenaria</italic>
</p></list-item><list-item><p>
<italic>capensis</italic>
</p></list-item><list-item><p>
<italic>fruticosa</italic>
</p></list-item><list-item><p>
<italic>galpinii</italic>
</p></list-item><list-item><p>
<italic>kurumanii</italic>
</p></list-item><list-item><p>
<italic>macrocephala</italic>
</p></list-item><list-item><p>
<italic>montana</italic>
</p></list-item><list-item><p>
<italic>picta</italic>
</p></list-item><list-item><p>
<italic>prostrata</italic>
</p></list-item><list-item><p>
<italic>schinzii</italic>
</p></list-item><list-item><p>
<italic>swazilandica</italic>
</p></list-item><list-item><p>
<italic>tomentosa</italic>
</p></list-item></list>
</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-04435-t002" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04435-t002_Table 2</object-id><label>Table 2</label><caption><p>The medicinal uses of <italic>D. anomala</italic> Sond.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Habitat</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Part(s) Used</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Medicinal Use</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country Practiced</th></tr></thead><tbody><tr><td rowspan="14" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Stony grasslands,<break/>rocky hillsides, and savanna forests.<break/>Altitude from 165 to 2075 meters. </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abdominal Pain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zimbabwe</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cardiovascular Diseases </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Namibia and South Africa</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Tuber</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Asthma</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Africa</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves and roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Breast Cancer </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lesotho</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cataracts</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zimbabwe</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Leaves and roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diabetes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lesotho and South Africa</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Renal Problems</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swaziland and South Africa</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malaria</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zimbabwe</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pneumonia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">South Africa and Zimbabwe</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Syphilis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Zimbabwe</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cough </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Malawi, Namibia, and South Africa</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hemorrhoids</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Namibia</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Root</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intestinal warms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lesotho, Malawi, and South Africa</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Flower and roots</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wounds and sores</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lesotho, Malawi, and South Africa</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-04435-t003" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04435-t003_Table 3</object-id><label>Table 3</label><caption><p>Shows phytochemical compounds and their role in cancer therapies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Plant Name</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Phytochemicals</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Role in Cancer Therapy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Nigella sativa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymoquinone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets the signal transducer and activator of transcription factor 3 (STAT3) pathway thereby leading to the inhibition of cancer cell proliferation.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B20-molecules-25-04435" ref-type="bibr">20</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Petroselinum crispum</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Apigenin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets intrinsic apoptotic pathways. In lung cancer, apigenin exert its effects by modulating signals between Akt and Snail/Slung signaling pathways leading to metastatic restrain of cancer cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B21-molecules-25-04435" ref-type="bibr">21</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Zingiber officianale</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6-Shogaol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets Akt and signal transducer and activator of transcription (STAT) signaling pathways. In NSCLC, 6-Shogaol directly regulates Akt1/2 pathways, which will in turn lead to the growth inhibition or induce apoptotic cell death.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B22-molecules-25-04435" ref-type="bibr">22</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Thymus vulgaris</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Thymol</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets the mitochondria and its effects induce mitochondrial malfunction and apoptosis of cancer cells.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B23-molecules-25-04435" ref-type="bibr">23</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Scutellaria baicalensis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baicalein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets mitogen-activated protein kinase (MARPK), extracellular signal-regulated kinase (ERK), and p38 signaling pathways. In colon cancer, Baicalin induces apoptosis and growth suppression.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B24-molecules-25-04435" ref-type="bibr">24</xref>,<xref rid="B25-molecules-25-04435" ref-type="bibr">25</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glycyrrhiza glabra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Glycyrrhizin </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets thromboxane A2 (TxA2) and signal transducer and activator of transcription (STAT) pathways.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B26-molecules-25-04435" ref-type="bibr">26</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Oldenlandia diffusa</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ursolic acid </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets and interferes with cancer protein Ki-67, CD31, and microRNA 29 (miR-29a). </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B27-molecules-25-04435" ref-type="bibr">27</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Melilotus officinalis</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dicumarol </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets pyruvate dehydrogenase kinase 1 (PDK1) leading to the interference of the intrinsic apoptotic pathway </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B28-molecules-25-04435" ref-type="bibr">28</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic>Glycyrrhiza glabra</italic>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Licochalcone A </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Targets cyclins and cyclin-dependent kinases (CDKs). Their interaction with the cyclins and CDKs results in cell cycle arrest in the G<sub>0</sub> or G<sub>1</sub> and G<sub>2</sub> or Mitotic phases.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B29-molecules-25-04435" ref-type="bibr">29</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="molecules-25-04435-t004" orientation="portrait" position="float"><object-id pub-id-type="pii">molecules-25-04435-t004_Table 4</object-id><label>Table 4</label><caption><p>The structure of major plant-derived anticancer compounds.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Anticancer Agent</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Structure</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Classification</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b1;-Humulene</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i001.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpenes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B50-molecules-25-04435" ref-type="bibr">50</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-farnesene</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i002.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Sesquiterpenes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B51-molecules-25-04435" ref-type="bibr">51</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cirsimaritin</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i003.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoids</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B52-molecules-25-04435" ref-type="bibr">52</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Scutellarein</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i004.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Flavonoids</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B53-molecules-25-04435" ref-type="bibr">53</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x003b2;-sitosterol</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i005.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Phytosterols</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B54-molecules-25-04435" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Stigmasterol</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i006.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Phytosterols</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B54-molecules-25-04435" ref-type="bibr">54</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Taraxasterol</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i007.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Phytosterols</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B55-molecules-25-04435" ref-type="bibr">55</xref>]</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lupeol</td><td align="center" valign="middle" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i008.jpg"/>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Triterpenes</td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref rid="B56-molecules-25-04435" ref-type="bibr">56</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lupenone</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<inline-graphic xlink:href="molecules-25-04435-i009.jpg"/>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Triterpenes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B57-molecules-25-04435" ref-type="bibr">57</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>